| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2010 | CN101229156B Medicine composition used for cardiovascular disorders |
| 07/07/2010 | CN101229141B Aspirin sustained release tablet and preparing method thereof |
| 07/07/2010 | CN101167743B Compound xylitol electrolyte injection and preparation method thereof |
| 07/07/2010 | CN101138557B Chlorhexidine acetate partial film forming gel composition and uses thereof |
| 07/07/2010 | CN101039939B Quinazolinylmethylene thiazolinones as CDK1 inhibitors |
| 07/07/2010 | CN101023973B Extract of polysaccharide of lithospermum erthrorhizon and composition containing same and use thereof |
| 07/07/2010 | CN101015545B Use of phenylpropionic acid and phenyl propyl compound with oxidation resistance function for protecting liver and brain damage |
| 07/07/2010 | CN101015544B Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage |
| 07/07/2010 | CN101015543B Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage |
| 07/07/2010 | CN101002930B Medicine composition containing aniracetam and brain protein hydrolyte |
| 07/06/2010 | USRE41425 Piperazine and piperidine compounds |
| 07/06/2010 | US7750199 Kit systems for granulated decontamination formulations |
| 07/06/2010 | US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/06/2010 | US7750161 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 07/06/2010 | US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds |
| 07/06/2010 | US7750158 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases |
| 07/06/2010 | US7750154 Amide derivatives |
| 07/06/2010 | US7750151 Inhibitors of Akt activity |
| 07/06/2010 | US7750150 Process for producing acid adduct salt of polyacidic base compound |
| 07/06/2010 | US7750148 chemical intermediates for making an oral antibiotics Sulbactam |
| 07/06/2010 | US7750145 sodium glucose co-transporter 2 inhibitors; for prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity |
| 07/06/2010 | US7750140 Ghrelin binding nucleic acids |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750053 Compositions and methods for alleviating hypertension or preventing a rise in blood pressure |
| 07/06/2010 | US7750052 Separately protonation of alcohol and water; blending; food processing |
| 07/06/2010 | US7750051 Amine oxidase inhibitors |
| 07/06/2010 | US7750050 Enhancing activity of an acid sphingomyelinase (ASM) protein with an analogue of ceramide, sphingomyelin or phosphonucleotide; gene therapy |
| 07/06/2010 | US7750049 vanilloid receptor antagonists such as 1-[4-(2-hydroxyethoxy)-2-bromo-5-methoxybenzyl]-3-[4-(trifluoromethyl)-benzyl]urea, useful for the treatment of neuropathic pain, urogenital disorders, hemorrhoids, inflammation, post-operative pain, respiratory and gastrointerstinal disorders |
| 07/06/2010 | US7750048 GPR40 agonists |
| 07/06/2010 | US7750047 benzoic acid derivatives, used as acetyltransferase enzyme inhibitors, used in the treatment of diseases due to defects in gene regulation predominantly cancer |
| 07/06/2010 | US7750046 Treatment of symptoms associated with irritable bowel syndrome |
| 07/06/2010 | US7750045 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/06/2010 | US7750044 Dimer poly-quaternary ester compounds |
| 07/06/2010 | US7750043 Retinoic esters with pinacol; antiproliferative agents; disorders caused by abnormal cellular differentiation; psoriasis, cancers of skin, colon, lungs, breasts, prostate, or ovaries, leukemia, neuroblastomas, eczema, acne; improved wrinkle resistance, skin hydration, sebum secretions |
| 07/06/2010 | US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects |
| 07/06/2010 | US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |
| 07/06/2010 | US7750040 G protein-coupled receptor S1P1/EDG1 agonists; low dosage, long lasting immunosuppressive effect; such as 1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid 2,4-dimethoxy-benzylamide |
| 07/06/2010 | US7750039 administering [7-(benzyloxy)-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone to mammals as analgesics, antiinflammatory agents and as neuroprotectants |
| 07/06/2010 | US7750038 1-methyl-5-[1-(methylsulfonyl)-2,3-dihydro-1H-indol-5-yl]-1H-pyrrole-2-carbonitrile; contraception; fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, and hormone-dependent carcinomas; providing hormone replacement therapy; stimulating food intake |
| 07/06/2010 | US7750037 Antidepressant |
| 07/06/2010 | US7750036 Carvedilol salts, corresponding compositions, methods of delivery and/or treatment |
| 07/06/2010 | US7750034 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 07/06/2010 | US7750033 administering an enzyme inhibitor of c-Jun N-terminal Kinase (JNK), Anthra[1-9-cd]pyrazol-6(2H)-one for treating the vascular aneurysm |
| 07/06/2010 | US7750032 Compounds and compositions as PPAR modulators |
| 07/06/2010 | US7750031 Caffeic acid derivative and composition containing the same |
| 07/06/2010 | US7750030 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 07/06/2010 | US7750029 administering (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide; treating urogenital disorders |
| 07/06/2010 | US7750028 treating epilepsy comprising administering polymorphic rufinamide's that differ with respect to their thermodynamic stability, in their physical parameters, such as the absorption pattern of infrared and raman spectrum analysis |
| 07/06/2010 | US7750027 Compounds having CRTH2 antagonist activity |
| 07/06/2010 | US7750026 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases |
| 07/06/2010 | US7750025 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 07/06/2010 | US7750024 [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid, 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one, or 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline; AMPA receptor antagonist; anticarcinogenic agents |
| 07/06/2010 | US7750023 Quinuclidine derivatives and medicinal compositions containing the same |
| 07/06/2010 | US7750022 modulators of nicotinic and/or of the monoamine receptors such as 3-(Dibenzofuran-2-yloxy)-1-azabicyclo[2.2.2]octane, useful for the treatment of nervous system disorders, neurodegenerative diseases and drug abuse and dependence |
| 07/06/2010 | US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection |
| 07/06/2010 | US7750020 3-Cyclopentyl-2-(4-cyclopropylsulfamoyl-phenyl)-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-propionamide; antidiabetic agent; insulin resistance, impaired glucose tolerance, obesity; with other hypolipidemic agent, anti-obesity and hypotensive agent |
| 07/06/2010 | US7750019 Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same |
| 07/06/2010 | US7750018 Use of carboxiamidotriazole (CAI) orotate in macular degeneration |
| 07/06/2010 | US7750017 Anticancer agents; hyperproliferative diseases; 4-(phenylamino)benzothieno[2,3-d]pyrimidines; inhibit the tyrosine kinase activities of EGFR (erbB1) and HER2 |
| 07/06/2010 | US7750016 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 07/06/2010 | US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 07/06/2010 | US7750014 Imidazo[1,2-C]pyrimidinylacetic acid derivatives |
| 07/06/2010 | US7750013 N-oxides as prodrugs of piperazine and piperidine derivatives |
| 07/06/2010 | US7750012 leukotriene A4 hydrolase inhibitors such as 4-{4-[4-(4-Iodo-phenoxy)-phenyl]-piperazin-1-yl]-butyric acid methyl ester, used for the treatment, prevention and/or prophylaxis of inflammatory diseases and disorders |
| 07/06/2010 | US7750011 Diazabicyclic aryl derivatives and their medical use |
| 07/06/2010 | US7750010 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches |
| 07/06/2010 | US7750009 7-benzyloxy-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine, uitable for treating respiratory system or gastrointestinal disorders, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system and cancers |
| 07/06/2010 | US7750008 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 07/06/2010 | US7750007 Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors |
| 07/06/2010 | US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/06/2010 | US7750005 Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments |
| 07/06/2010 | US7750004 Apoptosis promoters |
| 07/06/2010 | US7750003 mammalian target of rapamysin (mTOR)/phosphatidylinositol (PI) kinase-related kinase (PIKK) family inhibitor; antiproliferative, anticarcinogenic, antiinflammation agent, immunostimulant; |
| 07/06/2010 | US7750002 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders |
| 07/06/2010 | US7750001 2-(2-methylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; phosphatidylinositol 3-kinase (PI3K) inhibitor; transplantation of organs or tissues, inflammatory bowel diseases, psoriasis or atopic dermatitis, chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, scleroderma |
| 07/06/2010 | US7750000 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
| 07/06/2010 | US7749999 Alpha-ketoamides and derivatives thereof |
| 07/06/2010 | US7749998 urotensin antagonists such as N-[1-(4-biphenyl)-1)-2-(1-pyrrolidinyl)ethyl]-2-(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-N-methylacetamide, used for treating congestive heart failure, stroke, ischemia, angina, overactive bladder or arrhythmia |
| 07/06/2010 | US7749997 Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| 07/06/2010 | US7749996 Heterotricyclic metalloprotease inhibitors |
| 07/06/2010 | US7749995 modulator of cholesteryl ester transfer protein (CETP), such as 1,1,1-Trifluoro-3-[3-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-8-(3-trifluoromethoxy-phenyl)-2,3-dihydro-benzo[1,4]oxazin-4-yl]-propan-2-ol, used for treating cardiovascular disorders, dyslipidemia, and metabolic disorders |
| 07/06/2010 | US7749994 serine/threonine kinase inhibitors, useful for therapy and/or prophylaxis of cancers in mammals |
| 07/06/2010 | US7749993 Utillizing vasopressin antagonistic agent such as 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine; safe with few side effects |
| 07/06/2010 | US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders |
| 07/06/2010 | US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 07/06/2010 | US7749990 [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, useful for the treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 07/06/2010 | US7749989 Estrogenic compounds, methods of using and methods of administering the same |
| 07/06/2010 | US7749988 Triterpenoid derivatives |
| 07/06/2010 | US7749987 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 07/06/2010 | US7749986 Homogeneously formulating microdosed active principles |
| 07/06/2010 | US7749985 3-{[1-Isobutanoyloxyethoxy]carbonylamino}propyl(n-butyl)phosphinic acid, used treating a disease chosen from mild cognitive impairment, cognitive impairment associated with Alzheimer's disease, depression, anxiety and epilepsy; intermediates for 3-aminopropylphosphinic acid and analogs |
| 07/06/2010 | US7749984 drug design, a derivative of dextromethorphan having an imidazolidine group; calcium channel blockers |
| 07/06/2010 | US7749983 viricides; anticarcinogenic agents; biological conjugated drug |
| 07/06/2010 | US7749982 Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 07/06/2010 | US7749981 Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| 07/06/2010 | US7749980 purinergic receptor antagonists such as 6-{2,2-Dimethyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo [3,4-d][1,3]dioxol-4-ylmethoxy}-5-fluoro-nicotinic acid, used as analgesics |
| 07/06/2010 | US7749979 CpG DNA adjuvant in avian vaccines |
| 07/06/2010 | US7749978 Compositions and methods for inhibiting expression of Huntingtin gene |
| 07/06/2010 | US7749977 Therapeutic modulation of the Fas pathway |
| 07/06/2010 | US7749976 increasing insulin production by PTPMT1 positive cells by contacting PTPMT1-positive cells with a siRNA molecule that recognizes and binds PTPMT1 thereby regulating insulin production |